Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02829840
Brief Title: Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML)

First Submitted : July 5, 2016
First Submitted that Met QC Criteria : July 7, 2016
First Posted : July 12, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : June 1, 2017
Last Update Posted : June 2, 2017